This annual conference showcases the innovative approaches of Alzheimer’s Drug Discovery Foundation’s (ADDF) funded scientists and their newest results. In addition to featuring ADDF’s portfolio, the program also includes guest presentations focusing on the latest research in the Alzheimer’s disease field.
The 2021 program will feature five sessions:
- Clinical Trials and Novel Approaches for Dementia
- Advances in Fluid Biomarkers
- Drug Development Approaches for Frontotemporal Dementia
- Clinical Trials: Repurposing Approaches for Alzheimer’s Disease
- Neuroimaging and Digital Biomarkers for Dementia
Disclaimer: NIH Financial Conflict of Interest Statement